Walter Parker Moore Iii, MD | |
401 N 9th St, Bismarck, ND 58501-4530 | |
(701) 712-4500 | |
Not Available |
Full Name | Walter Parker Moore Iii |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 401 N 9th St, Bismarck, North Dakota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326021841 | NPI | - | NPPES |
139546901 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | H6450 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Walter Parker Moore Iii, MD 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 712-4500 | Walter Parker Moore Iii, MD 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 712-4500 |
News Archive
The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen Eileen M. Sullivan-Marx, PhD, RN, FAAN, dean of the New York University College of Nursing, as the 2013 recipient of the Doris Schwartz Gerontological Nursing Research Award.
Noting that Washington, D.C., has an adult HIV prevalence rate higher than some southern African countries that receive PEPFAR funding, GlobalPost writes that the International AIDS Conference, to be held in the U.S. for the first time in 22 years starting Sunday, has highlighted "that America is nowhere close to an AIDS-free generation at home."
A protein called isocitrate dehydrogenase is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
› Verified 9 days ago
Marcus M Fiechtner, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 715 E Broadway Ave Ste 110, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-6781 | |
Floyd R Barnhill Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Dr. Marie-pierre Charron, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 715 E Broadway Ave, Bismarck, ND 58501 Phone: 701-323-8922 | |
Andrew R Hetland, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2331 Tyler Pkwy Ste 6, Bismarck, ND 58503 Phone: 701-258-6851 | |
Dr. Jeffrey J Nelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-323-8922 Fax: 701-323-8018 | |
Dr. Steven D Spotts, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 |